Information Provided By:
Fly News Breaks for July 20, 2016
UNH
Jul 20, 2016 | 08:05 EDT
After the company posted "solid" Q2 results, Leerink analyst Ana Gupte raised her price target for UnitedHealth to $165 from $155 to reflect the likelihood of EPS upside in 2017 and the multiple expansion from recent Optum Rx wins in the marketplace that is a testimonial to the "uniquely differentiated" integrated business model. Leerink has an Outperform rating on the shares.
News For UNH From the Last 2 Days
UNH
Mar 28, 2024 | 15:22 EDT
What has Wall Street been buzzing about this week? Here are the top 5 Bu-y calls and the top 5 Sell calls made by Wall Street’s best analysts during the week of March 25-28. Find all top-rated... To see the rest of the story go to thefly.com. See Story Here
UNH
Mar 28, 2024 | 06:51 EDT
BofA downgraded Molina Healthcare (MOH) to Underperform from Neutral with a $439 price target. The firm, which is concerned that Molina and the Medicaid industry more broadly are likely to face rate pressure after a period of elevated margins, sees a less attractive risk/reward for Molina compared to other insurers the firm covers, the analyst tells investors. Molina is now trading roughly at parity with the firm's top pick in the space, UnitedHealth (UNH), compared to a 22% discount that had been seen over the last five years, helping to underscore the firm's view that "sentiment for Medicaid is nearing a top just at a time when Medicare is reaching a bottom," the analyst added.